Literature DB >> 20872290

Validation of basophil CD164 upregulation for pollen allergy diagnosis.

Anna Wolanczyk-Medrala1, Wojciech Barg, Jerzy Liebhart, Bernard Panaszek, Grazyna Nadobna, Marta Litwa, Grzegorz Gogolewski, Wojciech Medrala.   

Abstract

The aim of the study was to evaluate the sensitivity and specificity of allergen-induced basophil CD164 upregulation in patients with seasonal allergic rhinitis caused by allergy to grass pollens. This study was performed in 24 patients with allergy to grass pollens, and in 25 healthy controls. The protocol for allergen-induced basophil CD164 upregulation consisted of whole blood samples processing and staining with anti-CCR3/anti-CD164 antibodies added to a buffer at the beginning of stimulation. We observed dose-dependent allergen-induced basophil CD164 upregulation with 100% of specificity in both used allergen concentrations (12 and 1.2 ng/ml). Higher allergen concentration resulted in 100% and lower concentration in only 70.83% sensitivity. We have observed in the patients statistically significant correlations between anti-IgE stimulation and both allergen concentrations (for 12 ng/ml, r = 0.71, p < 0.0001; and for 1.2 ng/ml, r = 0.64, p < 0.001). We conclude that assessment of allergen-induced basophil CD164 upregulation is a very useful method for in vitro determination of allergy to grass pollens. This method seems to be a very promising tool in laboratory testing of allergies to other allergens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872290     DOI: 10.1007/s00005-010-0104-z

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  5 in total

1.  Increased IL-5 and IL-13 cytokine level in ex vivo stimulated whole blood cells from grass pollen allergic donors correlate with seasonal exposure.

Authors:  Anurag Singh; Sébastien Holvoet; Marietta Weiss; Maurice Beaumont; Adrian W Zuercher; Annick Mercenier
Journal:  Results Immunol       Date:  2011-07-27

2.  CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what's new?

Authors:  Salvatore Chirumbolo
Journal:  Clin Exp Med       Date:  2011-04-02       Impact factor: 3.984

Review 3.  Immunotherapy in allergy and cellular tests: state of art.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin Immunother       Date:  2014-05-02       Impact factor: 3.452

Review 4.  Update on the performance and application of basophil activation tests.

Authors:  Emily C McGowan; Sarbjit Saini
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

5.  Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro.

Authors:  Petr Heneberg; Kamila Riegerová; Petr Kučera
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.